Salsalate Pill for Endometriosis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
EndometriosisSalsalate Pill - Drug
Eligibility
18 - 45
Female
What conditions do you have?
Select

Study Summary

This trial is being conducted to study the effects of an emerging endometriosis treatment, on cardiovascular function in women with endometriosis.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

6 Primary · 3 Secondary · Reporting Duration: 5 days after treatment

5 days after treatment
Biopsy LOX-1 protein expression
Sera LOX-1 protein expression
brachial artery diameter and blood flow velocity
cutaneous vascular conductance
endothelial function
microvascular endothelial function
sera cytokine expression analysis
sera reproductive hormone analysis
skin biopsy biochemical analysis

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Salsalate
1 of 2
Placebo
1 of 2

Experimental Treatment

Non-Treatment Group

24 Total Participants · 2 Treatment Groups

Primary Treatment: Salsalate Pill · Has Placebo Group · Phase < 1

Salsalate
Drug
Experimental Group · 1 Intervention: Salsalate Pill · Intervention Types: Drug
Placebo
Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 days after treatment

Who is running the clinical trial?

Penn State UniversityLead Sponsor
319 Previous Clinical Trials
117,962 Total Patients Enrolled
3 Trials studying Endometriosis
152 Patients Enrolled for Endometriosis

Eligibility Criteria

Age 18 - 45 · Female Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are between the ages of 18 and 45 years of age

Who else is applying?

What state do they live in?
Massachusetts100.0%
How old are they?
18 - 65100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%